Joseph Bertroche, MD
Otolaryngology · West Des Moines, IANPI 1902288673
Payments from drug & device makers
What this record shows
Olympus Corporation Of The Americas accounts for 69.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,358 and has fallen 96.3% since, to $50 in 2025.
Across 22 payments — averaging $78.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$1K
- Stryker$221
- Inspire Medical Systems, Inc.$213
- Optinose US, Inc.$37
- Acclarent, Inc$19
- Olympus America Inc.$18
- plus $14 from 1 others
What the payments were for
- Travel & lodging$1,02860%
- Food & beverage$69040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 9 | $1,196 |
| Stryker | 3 | $221 |
| Inspire Medical Systems, Inc. | 6 | $213 |
| Optinose US, Inc. | 1 | $37 |
| Acclarent, Inc | 1 | $19 |
| Olympus America Inc. | 1 | $18 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PK Diego$1,107
- Celon System$1,107
- Olympus ENT Instruments$1,107
- SPIROX - LATERA$144
How this compares
$1,719 in reported general payments places this provider in the 65th percentile of 103 otolaryngology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 31 | $1,522 |
| Ipratropium Bromide | 33 | $1,349 |
| Ofloxacin | 38 | $1,206 |
| Fluticasone Propionate | 34 | $605 |
| Cephalexin | 50 | $560 |
| Azelastine Hcl | 20 | $416 |
| Omeprazole | 23 | $296 |
| Oxycodone Hcl | 41 | $155 |
| Montelukast Sodium | 41 | $153 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $84 |
| Tramadol Hcl | 27 | $60 |
| Clindamycin Hcl | 12 | $56 |
| Hydrochlorothiazide | 13 | $32 |
| Famotidine | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in West Des Moines
- Simon WrightWest Des Moines$21K
- Douglas HoisingtonWest Des Moines$8K
- Timothy SimplotWest Des Moines$6K
- Arun GuptaWest Des Moines$3K
- Eytan YoungWest Des Moines$2K
- Stephen GriffithWest Des Moines$2K
- Danielle LiudahlWest Des Moines$2K
- Richard RinehartWest Des Moines$954
- Maher YounesWest Des Moines$749
- Douglas SchulteWest Des Moines$587
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.